Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VolitionRX Limited Common Stock (NY:VNRX)

2.620 -0.020 (-0.76%)
Official Closing Price Updated: 6:30 PM EDT, Apr 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about VolitionRX Limited Common Stock

InvestorNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports Finger-Prick Breakthrough for Nucleosome Detection in Sepsis
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Over 95% Early-Stage Cancer Detection Using Capture-Seq Technology
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Completes Automation Validation for Nu.Q Vet Cancer Test in Japan
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports Multi-Pillar Clinical and Commercial Progress
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Appoints MBL as Distributor for Nu.Q(R) Discover Assays in Japan
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
Via Investor Brand Network
BioMedNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Study Shows Nu.Q Vet Feline Test Accurately Detects Lymphoma in Cats
Via Investor Brand Network
BioMedNewsBreaks — Volition Solves Liquid Biopsy’s “Needle in a Haystack” Problem; Achieves 180-fold (18,000%) Enrichment
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Nu.Q NETs Assay Selected for France’s National Sepsis Detection Initiative
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx (NYSE American: VNRX) Signs Co-Marketing and Services Agreement with Hologic (NASDAQ: HOLX)
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Signs Deal with Worldwide Leader in Specialized Diagnostics
Via Investor Brand Network
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) appoints PharmaVentures for Capture PCR(TM) and Oncology Portfolio Licensing
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) Highlights Latest Achievements in Mid-Year Review
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
News headline image
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
Via ACCESSWIRE
News headline image
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences
Via ACCESSWIRE
News headline image
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
News headline image
Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics
Via ACCESSWIRE
News headline image
Sidoti's August Micro-Cap Virtual Conference
Via ACCESSWIRE
News headline image
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
Via ACCESSWIRE
VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of Benzinga’s Healthcare Small Cap Conference
Via Investor Brand Network
News headline image
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation... 
From Sidoti & Company, LLC
Via AccessWire
News headline image
Sidoti Microcap Virtual Conference
A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 /... 
From Sidoti & Company, LLC
Via AccessWire
News headline image
Sidoti Microcap Virtual Conference
Presentation Times Released for 50 Presenting Companies Wednesday and Thursday, August 18-19, 2021 NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation... 
From Sidoti & Company, LLC
Via AccessWire
News headline image
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
News headline image
Sidoti Summer Virtual Small-Cap Conference
Presentation Times and Weblinks Released for Approximately 70 Presenting Companies Wednesday and Thursday, June 23-24, 2021 NEW YORK, NY / ACCESSWIRE / June 22, 2021 / Sidoti & Company, LLC has... 
From Sidoti & Company, LLC
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.